Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain

NICE guideline
Reference number: NG193
Published: 07 April 2021

History

Guidance published

Equality impact assessment Section 5 (PDF 97 KB)

Published:

07 April 2021
Committee member list (PDF 136 KB)

Published:

26 May 2021
Guidance consultation comments and response (PDF 25.61 MB)

Published:

23 June 2021

Stakeholder list updated

Stakeholder list (PDF 158 KB)

Published:

07 April 2021

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 410 KB)

Published:

03 August 2020
Evidence review (PDF 3.74 MB)

Published:

03 August 2020
Evidence review (PDF 1.57 MB)

Published:

03 August 2020
Evidence review (PDF 3.77 MB)

Published:

03 August 2020
Evidence review (PDF 936 KB)

Published:

03 August 2020
Evidence review (PDF 9.39 MB)

Published:

03 August 2020
Evidence review (PDF 7.67 MB)

Published:

03 August 2020
Evidence review (PDF 3.46 MB)

Published:

03 August 2020
Evidence review (PDF 3.71 MB)

Published:

03 August 2020
Evidence review (PDF 2.8 MB)

Published:

03 August 2020
Evidence review (PDF 5.32 MB)

Published:

03 August 2020
Economic report (PDF 2.45 MB)

Published:

03 August 2020
Guideline appendices (PDF 2.05 MB)

Published:

03 August 2020
Guideline appendices (PDF 1.05 MB)

Published:

03 August 2020
Economic report (PDF 127 KB)

Published:

03 August 2020
Comments form (MSWord 41 KB)

Published:

03 August 2020
Equality impact assessment (PDF 112 KB)

Published:

03 August 2020

Pre-consultation documents released

Economic plan (PDF 105 KB)

Published:

17 December 2019
Review questions (PDF 113 KB)

Published:

17 December 2019
Search strategies (PDF 4.31 MB)

Published:

17 December 2019

Declaration of interests

Register of interests (PDF 1.06 MB)

Published:

04 December 2019
Register of interests (PDF 1.49 MB)

Published:

24 May 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 360 KB)

Published:

06 February 2018
Minutes 2 (PDF 203 KB)

Published:

20 March 2018
Minutes 3 (PDF 252 KB)

Published:

01 May 2018
Minutes 4 (PDF 251 KB)

Published:

12 June 2018
Minutes 5 (PDF 170 KB)

Published:

24 July 2018
Minutes 6 (PDF 168 KB)

Published:

04 September 2018
Minutes 7 (PDF 174 KB)

Published:

15 October 2018
Minutes 8 (PDF 162 KB)

Published:

29 November 2018
Minutes 9 (PDF 176 KB)

Published:

31 January 2019
Minutes 10 (PDF 436 KB)

Published:

23 March 2019
Minutes 11 (PDF 199 KB)

Published:

23 May 2019
Minutes 11 July 2019 (PDF 170 KB)

Published:

01 October 2019
Minutes 19 September 2019 (PDF 398 KB)

Published:

04 December 2019

Equality and health inequalities assessment

Equality impact assessment 2 (PDF 227 KB)

Published:

02 February 2018

Scope published

Consultation comments and responses (PDF 1.45 MB)

Published:

31 January 2018
Final scope (PDF 284 KB)

Published:

31 January 2018

Draft scope consultation

Draft scope consultation
Comments form (MSWord 64 KB)

Published:

25 October 2017
Draft scope (PDF 356 KB)

Published:

25 October 2017
Equality impact assessment 1 (PDF 131 KB)

Published:

25 October 2017

Scoping workshop

Workshop notes (PDF 547 KB)

Published:

25 October 2017